Article Text
Letter
High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment
Statistics from Altmetric.com
Footnotes
-
Competing interests: None.
-
Informed consent was obtained for publication of the patient’s details described in this report.
Ethical approval: Ethics committee approval was secured for the study reported by the Stichting Slotervaartziekenhuis, Medisch Ethische Toetsingscommissie, Amsterdam.